Frank Rimerman Advisors LLC Purchases 156 Shares of The Clorox Company (NYSE:CLX)

Frank Rimerman Advisors LLC raised its position in The Clorox Company (NYSE:CLX) by 12.3% during the 4th quarter, HoldingsChannel reports. The fund owned 1,421 shares of the company’s stock after buying an additional 156 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Clorox were worth $231,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of CLX. Ilex Capital Partners UK LLP raised its stake in shares of Clorox by 512.7% during the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock worth $88,315,000 after purchasing an additional 453,624 shares in the last quarter. Amundi raised its stake in shares of Clorox by 42.6% during the 4th quarter. Amundi now owns 1,032,283 shares of the company’s stock worth $165,816,000 after purchasing an additional 308,234 shares in the last quarter. Assenagon Asset Management S.A. raised its stake in shares of Clorox by 302.0% during the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after purchasing an additional 265,455 shares in the last quarter. State Street Corp raised its stake in shares of Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Clorox during the 4th quarter worth approximately $37,935,000. Institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on CLX shares. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. DA Davidson dropped their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Barclays boosted their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Evercore ISI boosted their target price on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $159.62.

Clorox Stock Performance

Shares of NYSE CLX opened at $148.54 on Tuesday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock’s fifty day moving average price is $154.01 and its two-hundred day moving average price is $160.17. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The firm has a market cap of $18.30 billion, a price-to-earnings ratio of 40.58, a P/E/G ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company posted $2.16 EPS. On average, equities analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is currently 133.33%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.